Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by hobbs2969on Dec 23, 2021 11:57am
158 Views
Post# 34258185

RE:RE:Quantitative Equity Research Report

RE:RE:Quantitative Equity Research Report The Quantitative Equity Reasearch Report is found on RBC Direct Investing page,   If you click on the MDX ticker symbol and look down below the Anaylyst Research and Ratings title, you willl see it. Click to open it.  It gives MedX a five star price of less than 5 cents and a one star price greater than 84 cents.  Yesterday, they gave MedX a fair value of 16 cents and today its fair value is 19 cents.   We seem to want to keep slashing and burning our price back towards the 7 cent range which is significantly below today's SP fair value.  I look forward to the day that we are back up in the 19 cent range and beyond. 
<< Previous
Bullboard Posts
Next >>